Monoclonal Antibody Therapy in Treating Patients With Advanced or Recurrent Lymphoma

NCT00006009 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Lymphoma
Small Intestine Cancer

Interventions

BIOLOGICAL: visilizumab

Sponsor

Stanford University

Collaborators

[object Object]